Literature DB >> 2437184

Characterization of human autoantibodies that selectively precipitate the 7SL RNA component of the signal recognition particle.

N Okada, T Mimori, R Mukai, H Kashiwagi, J A Hardin.   

Abstract

The signal recognition particle (SRP), which consists of the 7SL RNA molecule associated with six polypeptides ranging between 9,000 and 72,000 m.w., mediates the translocation of newly synthesized proteins across the endoplasmic reticulum. We have characterized autoantibodies that are directed against this particle from two patients with rheumatic diseases. These sera immunoprecipitated the 7SL RNA from whole extracts of HeLa cells radiolabeled with 32P, but no RNA from deproteinized cell extracts. From 35S-methionine-labeled cell extracts, they immunoprecipitated a single polypeptide of 54,000 m.w. that is consistent with a known SRP component. Sucrose density gradient studies confirmed that this protein co-migrated with the 7SL RNA, indicating the likelihood that it is physically associated with this RNA. Thus, the 54,000 m.w. SRP protein, which is essential for the SRP functions of elongation arrest and translocation, appears to be a preferential target for human autoimmune responses. Human autoantibodies that recognize the SRP should be useful adjuncts to animal antisera for studies of the structure and function of this particle.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437184

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Autoantibody profiles in the sera of European patients with myositis.

Authors:  R Brouwer; G J Hengstman; W Vree Egberts; H Ehrfeld; B Bozic; A Ghirardello; G Grøndal; M Hietarinta; D Isenberg; J R Kalden; I Lundberg; H Moutsopoulos; P Roux-Lombard; J Vencovsky; A Wikman; H P Seelig; B G van Engelen ; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

Review 2.  snRNPs and scRNPs as autoantigens: clues to the etiology of the connective tissue diseases.

Authors:  J Craft; M Mamula; Y Ohosone; G Boire; H Gold; J Hardin
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

3.  Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis.

Authors:  L M Stinton; M Swain; R P Myers; A A Shaheen; M J Fritzler
Journal:  Clin Exp Immunol       Date:  2010-11-22       Impact factor: 4.330

Review 4.  Myositis-specific autoantibodies: detection and clinical associations.

Authors:  Sander H J van Dooren; Walther J van Venrooij; Ger J M Pruijn
Journal:  Auto Immun Highlights       Date:  2011-03-23

Review 5.  A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.

Authors:  Minoru Satoh; Shin Tanaka; Angela Ceribelli; S John Calise; Edward K L Chan
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

6.  Anti-signal recognition particle autoantibody ELISA validation and clinical associations.

Authors:  Rohit Aggarwal; Chester V Oddis; Danielle Goudeau; Noreen Fertig; Ilinca Metes; Chad Stephens; Zengbiao Qi; Diane Koontz; Marc C Levesque
Journal:  Rheumatology (Oxford)       Date:  2014-12-17       Impact factor: 7.580

7.  A novel apoptosis-inducing monoclonal antibody (anti-LHK) against a cell surface antigen on colon cancer cells.

Authors:  Hidehiko Matsukawa; Takanori Kanai; Makoto Naganuma; Nobuhiko Kamada; Tadakazu Hisamatsu; Hiromasa Takaishi; Haruhiko Ogata; Makio Mukai; Hiromasa Ishii; Tsuneyo Mimori; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2005-10       Impact factor: 7.527

8.  Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease.

Authors:  I N Targoff; F C Arnett; L Berman; C O'Brien; M Reichlin
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

Review 9.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

Review 10.  Immune-Mediated Necrotizing Myopathy.

Authors:  Iago Pinal-Fernandez; Maria Casal-Dominguez; Andrew L Mammen
Journal:  Curr Rheumatol Rep       Date:  2018-03-26       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.